Mylan Pharmaceuticals Inc. Recall: Tacrolimus Capsules, USP 5mg, 100-count bottle, Rx only
Mylan Pharmaceuticals Inc. Recall: Tacrolimus Capsules, USP 5mg, 100-count bottle, Rx only is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Mylan Pharmaceuticals Inc.; Product: Tacrolimus Capsules, USP 5mg, 100-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC
| Recalling firm | Mylan Pharmaceuticals Inc. |
|---|---|
| Product | Tacrolimus Capsules, USP 5mg, 100-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 0378-2047-01 |
| Reason for recall | Presence of foreign tablet/capsule - Potential presence of commingled one Tacrolimus 1 mg capsule in 5 mg bottles. |
| Classification | Class III (least serious — unlikely to cause adverse health consequences) |
| Status | Terminated |
| Distribution | U.S.A. Nationwide |
| Recall initiated | 20200323 |
| Recall number | D-1057-2020 |
| Category | drug |
| State | WV |
| Country | United States |
$29/mo
Try RecallGuard →